ArticleFrontiers in cardiovascular medicine2022

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022.

Si Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.